Medtronic, Inc.

Endeavor III clinical trial begins

Published in Law and Health Weekly, March 27th, 2004

Medtronic, Inc., (MDT) has begun enrollment in the Endeavor III clinical trial in the United States.

The first implant in the trial was conducted by Charles O'Shaughnessy, MD, Elyria Memorial Hospital, Elyria, Ohio, on February 19, 2004. Endeavor III is a clinical trial evaluating the safety and efficacy of the investigational Endeavor Drug Eluting Coronary Stent and is being conducted at 30 sites in the United States.

"We are pleased to be a part of this pivotal study, as the potential of having the Driver stent combined with a drug and polymer to evaluate restenosis and event rates is very important for our patients," said O'Shaughnessy, an expert...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2004-03-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry